Trending content from every aspect of the pharma supply chain takes front and center at CPHI North America in Philadelphia on April 25 – 27.
LBG’s Sayan Paria, who is looking forward to learning about the advancements in ESG and drug pricing, is excited to attend this informative event—Where American Pharma Meets the Global Market at Home.
“I hope to better understand the capabilities of CPHI attendees to assist partner/vendor selection with our commercial, USG, and NGO clients as well as to identify ways that we can work to support their goals —through strategic consulting, COGs analysis, financial and operational modeling, market research, new product development services, and non-dilutive funding services,” says Mr. Paria.
Sayan-Paria
Mr. Paria has a background in biochemistry, R&D strategy, and portfolio management and has been involved in the R&D industry for the past seven years. He possesses basic and translational biology lab experience, has supported grant funding activities, and has extensive corporate finance and operation experience. At LBG, he supports day-to-day aspects of projects, performs strategic analyses, conducts market research activities, and performs financial and operational modeling.
The premier event connecting the entire U.S. pharmaceutical drug development and manufacturing supply chain and the only pharma event in the Americas region to cover the end-to-end supply chain, CPHI North America brings together more than 3,000 attendees from more than 70 countries.
